Mercy Hospital for Women, is based in Heidelberg adjacent to the Austin Hospital. The hospital offers obstetric, gynaecological and neonatal services and has one of only four neonatal intensive care units in Victoria.

There are 229 beds in Mercy Hospital for Women.

During the past decade, Mercy Hospital for Women conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Hospital for Women" #1 sponsor was "Murdoch Childrens Research Institute" with 3 trials, followed by "AstraZeneca" with 2 trials sponsored, "McMaster University" with 2 trials sponsored, "University of Sydney" with 2 trials sponsored and "Clovis Oncology, Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Hospital for Women" #1 collaborator was "Mercy Hospital for Women, Australia" with 3 trials as a collaborator, "National Health and Medical Research Council, Australia" with 3 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator and "Myriad Genetic Laboratories, Inc." with 2 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Hospital for Women" are "Ovarian Cancer" (4 trials), "Fallopian Tube Cancer" (2 trials), "Advanced Ovarian Cancer" (1 trials), "Allergy" (1 trials) and "Anemia of Prematurity" (1 trials). Many other conditions were trialed in "Mercy Hospital for Women" in a lesser frequency.

Most popular intervention types in "Mercy Hospital for Women" are "Drug" (9 trials), "Procedure" (3 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Olaparib 300mg tablets" (2 trials), "0.9% Saline" (1 trials), "BCG" (1 trials), "BCG Vaccine" (1 trials) and "Caffeine citrate injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Hospital for Women" are 9 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Mercy Hospital for Women". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Mercy Hospital for Women, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Hospital for Women, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".